Loading view.
Live webinar on the use of generics, biosimilars and non-biologic complex drugs for multiple sclerosis
Save the date! The webinar will take place in Zoom and it will host two similar sessions: Because multiple sclerosis (MS) usually has an onset in early adulthood and is a progressive disease, the economic burden is substantial, and disease-modifying treatments (DMTs) constitute a large proportion of healthcare costs. The use of generic versions (of […]